Controlled Release of Vancomycin and Tigecycline from an Orthopaedic Implant Coating Prevents <i>Staphylococcus aureus</i> Infection in an Open Fracture Animal Model

<div>(a) <i>In vivo</i> bioluminescence images of a representative mouse from each group over the study period. (b) Mean <i>in vivo</i> bioluminescence signals throughout the study period.</div>

BioMed Research International

fig2

Figure 2

Figure 2: Controlled Release of Vancomycin and Tigecycline from an Orthopaedic Implant Coating Prevents <i>Staphylococcus aureus</i> Infection in an Open Fracture Animal Model 

Figure 2 | Controlled Release of Vancomycin and Tigecycline from an Orthopaedic Implant Coating Prevents Staphylococcus aureus Infection in an Open Fracture Animal Model 